B. Riley Wealth Advisors’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

B. Riley Wealth Advisors’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,101	Closed	-$17.1K	–	1572
2024 Q1	$17.1K	Buy	+11,101	New	+$10.2K	﹤0.01%	1429
2023 Q4	–	Sell	-11,101	Closed	-$17.1K	–	1495
2023 Q3	$17.1K	Buy	+11,101	New	+$14.4K	﹤0.01%	1429

Other funds holding RVPHW

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

B. Riley Wealth Advisors's RVPHW Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q2 2024, closing a stake of 11,101 shares — an estimated $17.1K sold.

B. Riley Wealth Advisors first reported a position in RVPHW in Q3 2023 and held it in 2 quarters. The position peaked at $17.1K in Q1 2024. 4 funds tracked by Wall St. Rank hold RVPHW as of Q2 2024.

B. Riley Wealth Advisors reported no remaining Reviva Pharmaceuticals Warrants position as of Q2 2024 after selling out during the quarter.
B. Riley Wealth Advisors sold 11,101 Reviva Pharmaceuticals Warrants shares in Q2 2024, an estimated $17.1K.
B. Riley Wealth Advisors first reported a position in Reviva Pharmaceuticals Warrants in Q3 2023 and held it in 2 quarters.
B. Riley Wealth Advisors's Reviva Pharmaceuticals Warrants position peaked at $17.1K in Q1 2024.
4 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.